A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_sessione0bb6b5650a6e0a281c70d35c77624d8de6c498f): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global New Psychoactive Substance Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

img

Global New Psychoactive Substance Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global New Psychoactive Substance Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

New Psychoactive Substance report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global New Psychoactive Substance market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Cancer and Neuropathic Disorders are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for New Psychoactive Substance industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, New Psychoactive Substance key companies include Zynerba Pharmaceuticals, GW Pharmaceuticals, Teewinot Life Sciences, AusCann, Cannabics Pharmaceuticals, Tilray, Cyrelian, Anandia Laboratories and InMed Pharmaceuticals, etc. Zynerba Pharmaceuticals, GW Pharmaceuticals, Teewinot Life Sciences are top 3 players and held % share in total in 2022.
New Psychoactive Substance can be divided into Stimulants, Cannabinoids, Hallucinogens and Depressants, etc. Stimulants is the mainstream product in the market, accounting for % share globally in 2022.
New Psychoactive Substance is widely used in various fields, such as Cancer, Neuropathic Disorders, Spasticity and Others, etc. Cancer provides greatest supports to the New Psychoactive Substance industry development. In 2022, global % share of New Psychoactive Substance went into Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global New Psychoactive Substance market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Zynerba Pharmaceuticals
GW Pharmaceuticals
Teewinot Life Sciences
AusCann
Cannabics Pharmaceuticals
Tilray
Cyrelian
Anandia Laboratories
InMed Pharmaceuticals
Renew Biopharma
Cronos Group
ICC International Cannabis
Biotii Technologies
Segment by Type
Stimulants
Cannabinoids
Hallucinogens
Depressants

Segment by Application


Cancer
Neuropathic Disorders
Spasticity
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the New Psychoactive Substance market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, New Psychoactive Substance introduction, etc. New Psychoactive Substance Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of New Psychoactive Substance market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of New Psychoactive Substance
1.1 New Psychoactive Substance Market Overview
1.1.1 New Psychoactive Substance Product Scope
1.1.2 New Psychoactive Substance Market Status and Outlook
1.2 Global New Psychoactive Substance Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global New Psychoactive Substance Market Size by Region (2018-2033)
1.4 Global New Psychoactive Substance Historic Market Size by Region (2018-2023)
1.5 Global New Psychoactive Substance Market Size Forecast by Region (2024-2033)
1.6 Key Regions, New Psychoactive Substance Market Size (2018-2033)
1.6.1 North America New Psychoactive Substance Market Size (2018-2033)
1.6.2 Europe New Psychoactive Substance Market Size (2018-2033)
1.6.3 Asia-Pacific New Psychoactive Substance Market Size (2018-2033)
1.6.4 Latin America New Psychoactive Substance Market Size (2018-2033)
1.6.5 Middle East & Africa New Psychoactive Substance Market Size (2018-2033)
2 New Psychoactive Substance Market by Type
2.1 Introduction
2.1.1 Stimulants
2.1.2 Cannabinoids
2.1.3 Hallucinogens
2.1.4 Depressants
2.2 Global New Psychoactive Substance Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global New Psychoactive Substance Historic Market Size by Type (2018-2023)
2.2.2 Global New Psychoactive Substance Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America New Psychoactive Substance Revenue Breakdown by Type (2018-2033)
2.3.2 Europe New Psychoactive Substance Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific New Psychoactive Substance Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America New Psychoactive Substance Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa New Psychoactive Substance Revenue Breakdown by Type (2018-2033)
3 New Psychoactive Substance Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Neuropathic Disorders
3.1.3 Spasticity
3.1.4 Others
3.2 Global New Psychoactive Substance Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global New Psychoactive Substance Historic Market Size by Application (2018-2023)
3.2.2 Global New Psychoactive Substance Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America New Psychoactive Substance Revenue Breakdown by Application (2018-2033)
3.3.2 Europe New Psychoactive Substance Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific New Psychoactive Substance Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America New Psychoactive Substance Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa New Psychoactive Substance Revenue Breakdown by Application (2018-2033)
4 New Psychoactive Substance Competition Analysis by Players
4.1 Global New Psychoactive Substance Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in New Psychoactive Substance as of 2022)
4.3 Date of Key Players Enter into New Psychoactive Substance Market
4.4 Global Top Players New Psychoactive Substance Headquarters and Area Served
4.5 Key Players New Psychoactive Substance Product Solution and Service
4.6 Competitive Status
4.6.1 New Psychoactive Substance Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Zynerba Pharmaceuticals
5.1.1 Zynerba Pharmaceuticals Profile
5.1.2 Zynerba Pharmaceuticals Main Business
5.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Products, Services and Solutions
5.1.4 Zynerba Pharmaceuticals New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.1.5 Zynerba Pharmaceuticals Recent Developments
5.2 GW Pharmaceuticals
5.2.1 GW Pharmaceuticals Profile
5.2.2 GW Pharmaceuticals Main Business
5.2.3 GW Pharmaceuticals New Psychoactive Substance Products, Services and Solutions
5.2.4 GW Pharmaceuticals New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.2.5 GW Pharmaceuticals Recent Developments
5.3 Teewinot Life Sciences
5.3.1 Teewinot Life Sciences Profile
5.3.2 Teewinot Life Sciences Main Business
5.3.3 Teewinot Life Sciences New Psychoactive Substance Products, Services and Solutions
5.3.4 Teewinot Life Sciences New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.3.5 AusCann Recent Developments
5.4 AusCann
5.4.1 AusCann Profile
5.4.2 AusCann Main Business
5.4.3 AusCann New Psychoactive Substance Products, Services and Solutions
5.4.4 AusCann New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.4.5 AusCann Recent Developments
5.5 Cannabics Pharmaceuticals
5.5.1 Cannabics Pharmaceuticals Profile
5.5.2 Cannabics Pharmaceuticals Main Business
5.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Products, Services and Solutions
5.5.4 Cannabics Pharmaceuticals New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.5.5 Cannabics Pharmaceuticals Recent Developments
5.6 Tilray
5.6.1 Tilray Profile
5.6.2 Tilray Main Business
5.6.3 Tilray New Psychoactive Substance Products, Services and Solutions
5.6.4 Tilray New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.6.5 Tilray Recent Developments
5.7 Cyrelian
5.7.1 Cyrelian Profile
5.7.2 Cyrelian Main Business
5.7.3 Cyrelian New Psychoactive Substance Products, Services and Solutions
5.7.4 Cyrelian New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.7.5 Cyrelian Recent Developments
5.8 Anandia Laboratories
5.8.1 Anandia Laboratories Profile
5.8.2 Anandia Laboratories Main Business
5.8.3 Anandia Laboratories New Psychoactive Substance Products, Services and Solutions
5.8.4 Anandia Laboratories New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.8.5 Anandia Laboratories Recent Developments
5.9 InMed Pharmaceuticals
5.9.1 InMed Pharmaceuticals Profile
5.9.2 InMed Pharmaceuticals Main Business
5.9.3 InMed Pharmaceuticals New Psychoactive Substance Products, Services and Solutions
5.9.4 InMed Pharmaceuticals New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.9.5 InMed Pharmaceuticals Recent Developments
5.10 Renew Biopharma
5.10.1 Renew Biopharma Profile
5.10.2 Renew Biopharma Main Business
5.10.3 Renew Biopharma New Psychoactive Substance Products, Services and Solutions
5.10.4 Renew Biopharma New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.10.5 Renew Biopharma Recent Developments
5.11 Cronos Group
5.11.1 Cronos Group Profile
5.11.2 Cronos Group Main Business
5.11.3 Cronos Group New Psychoactive Substance Products, Services and Solutions
5.11.4 Cronos Group New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.11.5 Cronos Group Recent Developments
5.12 ICC International Cannabis
5.12.1 ICC International Cannabis Profile
5.12.2 ICC International Cannabis Main Business
5.12.3 ICC International Cannabis New Psychoactive Substance Products, Services and Solutions
5.12.4 ICC International Cannabis New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.12.5 ICC International Cannabis Recent Developments
5.13 Biotii Technologies
5.13.1 Biotii Technologies Profile
5.13.2 Biotii Technologies Main Business
5.13.3 Biotii Technologies New Psychoactive Substance Products, Services and Solutions
5.13.4 Biotii Technologies New Psychoactive Substance Revenue (US$ Million) & (2018-2023)
5.13.5 Biotii Technologies Recent Developments
6 North America
6.1 North America New Psychoactive Substance Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe New Psychoactive Substance Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific New Psychoactive Substance Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America New Psychoactive Substance Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa New Psychoactive Substance Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 New Psychoactive Substance Market Dynamics
11.1 New Psychoactive Substance Industry Trends
11.2 New Psychoactive Substance Market Drivers
11.3 New Psychoactive Substance Market Challenges
11.4 New Psychoactive Substance Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market New Psychoactive Substance Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global New Psychoactive Substance Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global New Psychoactive Substance Market Size Share by Region (2018-2023)
Table 4. Global New Psychoactive Substance Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global New Psychoactive Substance Forecasted Market Size Share by Region (2024-2033)
Table 6. Global New Psychoactive Substance Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global New Psychoactive Substance Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global New Psychoactive Substance Revenue Market Share by Type (2018-2023)
Table 9. Global New Psychoactive Substance Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global New Psychoactive Substance Revenue Market Share by Type (2024-2033)
Table 11. North America New Psychoactive Substance Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America New Psychoactive Substance Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe New Psychoactive Substance Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe New Psychoactive Substance Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific New Psychoactive Substance Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific New Psychoactive Substance Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America New Psychoactive Substance Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America New Psychoactive Substance Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa New Psychoactive Substance Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa New Psychoactive Substance Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global New Psychoactive Substance Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global New Psychoactive Substance Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global New Psychoactive Substance Revenue Market Share by Application (2018-2023)
Table 24. Global New Psychoactive Substance Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global New Psychoactive Substance Revenue Market Share by Application (2024-2033)
Table 26. North America New Psychoactive Substance Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America New Psychoactive Substance Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe New Psychoactive Substance Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe New Psychoactive Substance Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific New Psychoactive Substance Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific New Psychoactive Substance Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America New Psychoactive Substance Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America New Psychoactive Substance Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa New Psychoactive Substance Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa New Psychoactive Substance Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global New Psychoactive Substance Revenue (US$ Million) by Players (2018-2023)
Table 37. Global New Psychoactive Substance Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in New Psychoactive Substance as of 2022)
Table 39. Date of Key Players Enter into New Psychoactive Substance Market
Table 40. Global New Psychoactive Substance Key Players Headquarters and Area Served
Table 41. New Psychoactive Substance Product Solution and Service
Table 42. Global New Psychoactive Substance Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Zynerba Pharmaceuticals Basic Information List
Table 45. Zynerba Pharmaceuticals Description and Business Overview
Table 46. Zynerba Pharmaceuticals New Psychoactive Substance Products, Services and Solutions
Table 47. Revenue (US$ Million) in New Psychoactive Substance Business of Zynerba Pharmaceuticals (2018-2023)
Table 48. Zynerba Pharmaceuticals Recent Developments
Table 49. GW Pharmaceuticals Basic Information List
Table 50. GW Pharmaceuticals Description and Business Overview
Table 51. GW Pharmaceuticals New Psychoactive Substance Products, Services and Solutions
Table 52. Revenue (US$ Million) in New Psychoactive Substance Business of GW Pharmaceuticals (2018-2023)
Table 53. GW Pharmaceuticals Recent Developments
Table 54. Teewinot Life Sciences Basic Information List
Table 55. Teewinot Life Sciences Description and Business Overview
Table 56. Teewinot Life Sciences New Psychoactive Substance Products, Services and Solutions
Table 57. Revenue (US$ Million) in New Psychoactive Substance Business of Teewinot Life Sciences (2018-2023)
Table 58. Teewinot Life Sciences Recent Developments
Table 59. AusCann Basic Information List
Table 60. AusCann Description and Business Overview
Table 61. AusCann New Psychoactive Substance Products, Services and Solutions
Table 62. Revenue (US$ Million) in New Psychoactive Substance Business of AusCann (2018-2023)
Table 63. AusCann Recent Developments
Table 64. Cannabics Pharmaceuticals Basic Information List
Table 65. Cannabics Pharmaceuticals Description and Business Overview
Table 66. Cannabics Pharmaceuticals New Psychoactive Substance Products, Services and Solutions
Table 67. Revenue (US$ Million) in New Psychoactive Substance Business of Cannabics Pharmaceuticals (2018-2023)
Table 68. Cannabics Pharmaceuticals Recent Developments
Table 69. Tilray Basic Information List
Table 70. Tilray Description and Business Overview
Table 71. Tilray New Psychoactive Substance Products, Services and Solutions
Table 72. Revenue (US$ Million) in New Psychoactive Substance Business of Tilray (2018-2023)
Table 73. Tilray Recent Developments
Table 74. Cyrelian Basic Information List
Table 75. Cyrelian Description and Business Overview
Table 76. Cyrelian New Psychoactive Substance Products, Services and Solutions
Table 77. Revenue (US$ Million) in New Psychoactive Substance Business of Cyrelian (2018-2023)
Table 78. Cyrelian Recent Developments
Table 79. Anandia Laboratories Basic Information List
Table 80. Anandia Laboratories Description and Business Overview
Table 81. Anandia Laboratories New Psychoactive Substance Products, Services and Solutions
Table 82. Revenue (US$ Million) in New Psychoactive Substance Business of Anandia Laboratories (2018-2023)
Table 83. Anandia Laboratories Recent Developments
Table 84. InMed Pharmaceuticals Basic Information List
Table 85. InMed Pharmaceuticals Description and Business Overview
Table 86. InMed Pharmaceuticals New Psychoactive Substance Products, Services and Solutions
Table 87. Revenue (US$ Million) in New Psychoactive Substance Business of InMed Pharmaceuticals (2018-2023)
Table 88. InMed Pharmaceuticals Recent Developments
Table 89. Renew Biopharma Basic Information List
Table 90. Renew Biopharma Description and Business Overview
Table 91. Renew Biopharma New Psychoactive Substance Products, Services and Solutions
Table 92. Revenue (US$ Million) in New Psychoactive Substance Business of Renew Biopharma (2018-2023)
Table 93. Renew Biopharma Recent Developments
Table 94. Cronos Group Basic Information List
Table 95. Cronos Group Description and Business Overview
Table 96. Cronos Group New Psychoactive Substance Products, Services and Solutions
Table 97. Revenue (US$ Million) in New Psychoactive Substance Business of Cronos Group (2018-2023)
Table 98. Cronos Group Recent Developments
Table 99. ICC International Cannabis Basic Information List
Table 100. ICC International Cannabis Description and Business Overview
Table 101. ICC International Cannabis New Psychoactive Substance Products, Services and Solutions
Table 102. Revenue (US$ Million) in New Psychoactive Substance Business of ICC International Cannabis (2018-2023)
Table 103. ICC International Cannabis Recent Developments
Table 104. Biotii Technologies Basic Information List
Table 105. Biotii Technologies Description and Business Overview
Table 106. Biotii Technologies New Psychoactive Substance Products, Services and Solutions
Table 107. Revenue (US$ Million) in New Psychoactive Substance Business of Biotii Technologies (2018-2023)
Table 108. Biotii Technologies Recent Developments
Table 109. North America New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 110. North America New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 111. Europe New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 112. Europe New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 113. Asia-Pacific New Psychoactive Substance Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 114. Asia-Pacific New Psychoactive Substance Market Size by Region (2018-2023) & (US$ Million)
Table 115. Asia-Pacific New Psychoactive Substance Market Size by Region (2024-2033) & (US$ Million)
Table 116. Asia-Pacific New Psychoactive Substance Market Share by Region (2018-2023)
Table 117. Asia-Pacific New Psychoactive Substance Market Share by Region (2024-2033)
Table 118. Latin America New Psychoactive Substance Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 119. Latin America New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 120. Latin America New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 121. Middle East & Africa New Psychoactive Substance Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 122. Middle East & Africa New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 123. Middle East & Africa New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 124. New Psychoactive Substance Market Trends
Table 125. New Psychoactive Substance Market Drivers
Table 126. New Psychoactive Substance Market Challenges
Table 127. New Psychoactive Substance Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global New Psychoactive Substance Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global New Psychoactive Substance Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global New Psychoactive Substance Market Share by Regions: 2022 VS 2033
Figure 4. Global New Psychoactive Substance Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America New Psychoactive Substance Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe New Psychoactive Substance Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific New Psychoactive Substance Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America New Psychoactive Substance Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa New Psychoactive Substance Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Stimulants
Figure 11. Global Stimulants Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Cannabinoids
Figure 13. Global Cannabinoids Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Hallucinogens
Figure 15. Global Hallucinogens Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Depressants
Figure 17. Global Depressants Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Global New Psychoactive Substance Market Size Share by Type: 2022 & 2033
Figure 19. North America New Psychoactive Substance Revenue Market Share by Type (2018-2033)
Figure 20. Europe New Psychoactive Substance Revenue Market Share by Type (2018-2033)
Figure 21. Asia-Pacific New Psychoactive Substance Revenue Market Share by Type (2018-2033)
Figure 22. Latin America New Psychoactive Substance Revenue Market Share by Type (2018-2033)
Figure 23. Middle East and Africa New Psychoactive Substance Revenue Market Share by Type (2018-2033)
Figure 24. Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Neuropathic Disorders Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Spasticity Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Global New Psychoactive Substance Market Size Share by Application: 2022 & 2033
Figure 29. North America New Psychoactive Substance Revenue Market Share by Application (2018-2033)
Figure 30. Europe New Psychoactive Substance Revenue Market Share by Application (2018-2033)
Figure 31. Asia-Pacific New Psychoactive Substance Revenue Market Share by Application (2018-2033)
Figure 32. Latin America New Psychoactive Substance Revenue Market Share by Application (2018-2033)
Figure 33. Middle East and Africa New Psychoactive Substance Revenue Market Share by Application (2018-2033)
Figure 34. New Psychoactive Substance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 35. Global Top 5 and Top 10 Players New Psychoactive Substance Market Share in 2022
Figure 36. North America New Psychoactive Substance Market Share by Country (2018-2033)
Figure 37. United States New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 38. Canada New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 39. Germany New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 40. France New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 41. U.K. New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 42. Italy New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 43. Russia New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 44. Nordic Countries New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 45. Asia-Pacific New Psychoactive Substance Market Share by Region (2018-2033)
Figure 46. China New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 47. Japan New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 48. South Korea New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 49. Southeast Asia New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 50. India New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 51. Australia New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 52. Latin America New Psychoactive Substance Market Share by Country (2018-2033)
Figure 53. Mexico New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 54. Brazil New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 55. Middle East & Africa New Psychoactive Substance Market Share by Country (2018-2033)
Figure 56. Turkey New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 58. UAE New Psychoactive Substance Market Size (2018-2033) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries